Coughlin Timothy Insider Trading Activity

Also formerly known as Coughlin Timothy P
Average Profitability
11.55%
Insider Buys Quantity
1
Insider Buys Sum
$299,994.80
Insider Sells Quantity
33
Insider Sells Sum
$15.27M

Insider Activity of Coughlin Timothy

According to the SEC Form 4 filings, Coughlin Timothy, being in a position of

  1. director at Travere Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 13250 shares for $642,090,
    over all time since 2025-10-31, has bought 0 shares, and sold 31250 shares for $1.27M.

Biography of Coughlin Timothy

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $642,0902100

Comparison of Insiders on Amount of Buys and Sells

2026-06-12SaleTravere Therapeutics, Inc.
TVTX
director
10,000
0.0103%
$50.07$500,747+10.22%
2026-05-15SaleTravere Therapeutics, Inc.
TVTX
director
3,250
0.0036%
$43.49$141,343+33.08%
2025-10-31SaleTravere Therapeutics, Inc.
TVTX
director
18,000
0.0206%
$35.03$630,601+21.15%
2022-06-03SaleFate Therapeutics, Inc.
FATE
1,439
0.0014%
$22.81$32,824-19.37%
2017-02-06SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
963
0.0011%
$43.14$41,544+24.02%
2017-02-03SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,500
0.0017%
$42.55$63,825+23.74%
2017-01-17SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,750
0.002%
$40.65$71,138+31.5%
2017-01-10SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,750
0.002%
$43.37$75,898+23.56%
2016-11-23PurchaseFate Therapeutics, Inc.
FATE
director
112,780
0.245%
$2.66$299,995+11.55%
2016-02-03SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,500
0.0017%
$38.06$57,090+15.18%
2016-01-19SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,750
0.0021%
$46.69$81,708-0.89%
2016-01-11SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,750
0.002%
$44.25$77,438+2.78%
2015-10-16SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
25,000
0.0295%
$47.78$1.19M+0.15%
2015-07-20SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
20,000
0.0244%
$55.00$1.1M-11.04%
2015-07-13SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
20,000
0.0231%
$50.00$1M-7.41%
2015-06-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
60,000
0.0699%
$45.08$2.7M+3.67%
2015-03-20SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
40,000
0.0508%
$44.49$1.78M+5.73%
2015-01-16SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,750
0.0021%
$30.81$53,918+45.6%
2015-01-12SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
3,500
0.0042%
$28.37$99,295+54.85%
2015-01-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
20,000
0.0135%
$14.92$298,400+65.94%
Total: 37
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.